APOC3 and familial chylomicronemia syndrome: Our observations of a APOC3 LPL-independent triglyceride-related pathway agree with Gaudet et al,48 testing the effects of an APOC3 mRNA inhibitor on familial chylomicronemia syndrome sufferers.